We hypothesized that the combination of the PFKFB3 inhibitor 3PO with the autophagy inhibitor CQ might lead to a significant improvement in the anti-cancer effects of 3PO in vitro and that this combination might also increase efficacy of 3PO as an anti-tumor agent in vivo. The gene discussed is PFKFB3; the disease is neoplasm.